Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of neurotoxic antineoplastic agents commonly used to treat cancer. Patients with CIPN experience debilitating signs and symptoms, such as combinations of tingling, numbness, pain, and cramping in the hands and feet that inhibit t...
Main Authors: | Kaitlin H. Chung, Susanna B. Park, Fiona Streckmann, Joachim Wiskemann, Nimish Mohile, Amber S. Kleckner, Luana Colloca, Susan G. Dorsey, Ian R. Kleckner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/5/1224 |
Similar Items
-
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01) -
Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives
by: Katarzyna Szklener, et al.
Published: (2023-03-01) -
Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice
by: Aryah Basu, et al.
Published: (2024-01-01) -
Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01) -
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy
by: Mohamad Mroué, et al.
Published: (2024-01-01)